Finnegan Beats Humira IP Licensing Claims for AbbVie

, The Litigation Daily

   | 0 Comments

A U.K. arthritis research trust overreached by demanding more patent royalties from drugmaker and longtime licensee AbbVie, an appeals court ruled on Thursday.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202667648803

Thank you!

This article's comments will be reviewed.